Home » Information and Communications Technology » Software & Solutions » Pharmaceutical Contract Sales Outsourcing (CSO) Market

Artificial Cornea and Corneal Implant Market By Corneal Implant Types (Artificial Cornea, Keratoprosthesis (KPro), Amniotic Membrane, Corneal Inlays, Others); Indication (Corneal Transplantation, Keratoconus, Fuchs’ Dystrophy, Corneal Scarring, Others); End-user (Hospitals, Ambulatory Surgical Centers, Ophthalmology Clinics); Implant Materials (Synthetic Materials, Biological Materials); Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $4999

Published: | Report ID: 19735 | Report Format : PDF

Key Highlights of the Report

The global pharmaceutical contract sales outsourcing (CSO) market are segmented by service, therapeutic area, and region. The personal promotion segment is the most popular service segment. Cardiovascular disorders is the top leading therapeutic area segment, with North America leading the market growth.

The global pharmaceutical contract sales outsourcing (CSO) market have been driven by several factors, such as the as pharmaceutical companies are increasingly looking to streamline their operations and reduce costs, making (CSO) an attractive option for sales functions & expanded the reach of pharmaceutical companies due to globalization. However, the market also faces significant challenges, including concerns regarding data security and confidentiality when outsourcing sales functions, particularly due to the sensitive nature of pharmaceutical industry information.

Nonetheless, the global pharmaceutical contract sales outsourcing (CSO) market offers significant growth opportunities, such as CSO offering pharmaceutical companies access to a highly trained and specialized sales force without the need for extensive recruitment and training efforts.

Market Overview

The global pharmaceutical contract sales outsourcing (CSO) market has witnessed steady growth in recent years and is expected to grow at a CAGR of 7.30% between 2023 and 2030. The market was valued at USD 9.3 billion in 2022 and is expected to reach USD 15.22933719 billion in 2030.

What Are the Main Drivers Of The Global Pharmaceutical contract sales outsourcing (CSO) Market?

The global pharmaceutical contract sales outsourcing (CSO) market is driven by several factors, such as pharmaceutical companies are increasingly looking to streamline their operations and reduce costs, making (CSO) an attractive option for sales functions & expanded the reach of pharmaceutical companies due to globalization.

What Are the Major Challenges Faced by The Global pharmaceutical contract sales outsourcing (CSO) Market?

The global pharmaceutical contract sales outsourcing (CSO) market also face several challenges, such as concerns regarding data security and confidentiality when outsourcing sales functions, particularly due to the sensitive nature of pharmaceutical industry information.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

What Are the Growth Opportunities in The Global Pharmaceutical contract sales outsourcing (CSO) market?

The global pharmaceutical contract sales outsourcing (CSO) market offers significant growth opportunities, such as CSO offering pharmaceutical companies access to a highly trained and specialized sales force without the need for extensive recruitment and training efforts.

Executive Summary

Overview of the Global pharmaceutical contract sales outsourcing (CSO) market

The global pharmaceutical contract sales outsourcing (CSO) market has been steadily growing in recent years due to the expanding nature of pharmaceutical companies due to globalization, and pharmaceutical companies are increasingly looking to streamline their operations and reduce costs, making (CSO) an attractive option for sales functions.

Market Definition

The global pharmaceutical contract sales outsourcing ((CSO)) market refers to the practice of pharmaceutical companies partnering with external service providers to outsource their sales and marketing functions. In this arrangement, the CSO are responsible for promoting and selling the pharmaceutical company’s products to healthcare professionals. It may provide a range of services, including sales representatives, field forces, telesales, market research, and analytics. The goal of pharmaceutical CSO is to enhance sales effectiveness, expand market reach, and improve operational efficiency for the pharmaceutical companies. Pharmaceutical firms may concentrate on their core capabilities while utilising the external sales experience that CSO frequently bring with them in the form of specialised knowledge, resources, and flexibility.

Market Insights

  • The global demand for pharmaceutical contract sales outsourcing (CSO) was valued at USD 9.3 Billion in 2022 and is expected to reach USD 15.22933719 Billion in 2030, growing at a CAGR of 7.30% between 2023 and 2030.
  • Personal promotion service is the leading segment and held more than four-fifth of the share in terms of value in 2022.
  • Cardiovascular Disorders is expected to post the highest CAGR during the forecast period & leading the market share with more than 35% share in 2022, while the metabolic disorders therapeutic area segment is likely to exhibit the fastest CAGR during the forecast period.
  • North America is fueling the growth of the pharmaceutical contract sales outsourcing (CSO) industry with a nearly three-firth share in 2022, while Europe and Asia-pacific collectively accounted for just nearly under 65% share in 2022. Europe held more than 40% share in 2022.
  • The major driver that drives the market is that pharmaceutical companies are increasingly looking to streamline their operations and & expand the reach of pharmaceutical companies due to globalization.
  • At the same time, increasing scrutiny and regulations within the healthcare industry that can impact the operations and compliance of CSO are the main restraints.
  • It offers pharmaceutical companies access to a highly trained and specialized sales force without the need for extensive recruitment and training efforts are some of the major opportunities in the market.

Segmentation by Therapeutic area

  • The Cardiovascular Disorders Service is the leading segment and held more than 35% share in value in 2022.
  • The metabolic disorders therapeutic area segment is likely to exhibit the fastest CAGR during the forecast period.

Segmentation by Service

  • The personal promotion service segment governs the demand for the pharmaceutical contract sales outsourcing (CSO) industry globally, holding a four-fifth share, and is also expected to grow at a rapid CAGR.
  • Non-personal Promotion Service held massive CAGR for pharmaceutical contract sales outsourcing (CSO) market.

Segmentation by Region

  • North America was fueling the growth of the pharmaceutical contract sales outsourcing (CSO) industry with a nearly two-third share in 2022.
  • Europe and Asia-pacific collectively account for nearly under 65% share in 2022, with Europe held more than 40% share in 2022.
  • The rest of the world, including Latin America, The Middle East, and Africa, contributes the remainder to the demand for pharmaceutical contract sales outsourcing (CSO).

As pharmaceutical companies are increasingly looking to streamline their operations and reduce costs, making (CSO) an attractive option for sales functions also expanded the reach of pharmaceutical companies due to globalization driving the market.

The US pharmaceutical companies are increasingly seeking cost-effective solutions to streamline their operations. By outsourcing sales functions to CSO, they can reduce overhead costs associated with recruiting, training, and managing an in-house sales force. The healthcare landscape in the US is evolving rapidly, with complex regulations and market dynamics. CSO offer specialized expertise and knowledge in navigating these challenges, ensuring compliance, and maximizing sales potential. Additionally, advancements in technology and data analytics have enhanced the capabilities of CSO. They can leverage data-driven insights to identify key market trends, target healthcare professionals more effectively, and track sales performance.

Japan has a rapidly aging population, resulting in an increased demand for healthcare services and pharmaceutical products. This has led pharmaceutical companies to expand their market presence and sales efforts, creating opportunities for CSO to support their sales and marketing activities. The Japanese healthcare landscape is characterized by a high level of fragmentation, with various regional and specialty-focused healthcare providers. CSO can provide local market knowledge, establish relationships with key healthcare professionals, and customize sales strategies to target specific regions or therapeutic areas.

Increasingly seeking cost-effective solutions

Pharmaceutical companies are increasingly seeking cost-effective solutions to optimize their operations. Outsourcing sales functions to CSO can result in significant cost savings. For example, a pharmaceutical company may have a seasonal product that requires a dedicated sales force only during specific months of the year. Instead of maintaining a full-time in-house sales team, the company can partner with a (CSO) to provide a flexible sales force that can be scaled up or down as needed. This allows the company to reduce fixed costs associated with salaries, benefits, and infrastructure, ultimately improving their cost efficiency.

Specialized Expertise and market knowledge

The healthcare industry, including the pharmaceutical sector, is becoming increasingly complex and specialized. CSO offer specialized expertise and market knowledge, enabling pharmaceutical companies to benefit from their experience and insights. For instance, a pharmaceutical company developing a new rare disease drug may lack in-house expertise in that specific therapeutic area. By partnering with a (CSO) that specializes in rare diseases, the company can leverage their deep understanding of the target patient population, treatment landscape, and physician network. The (CSO) can provide tailored sales strategies, key opinion leader (KOL) engagement, and insights into market dynamics, maximizing the product’s potential in a niche market.

Potential Risk to Reputation and Loss of Customer Relationships

Pharmaceutical companies often build strong relationships with healthcare professionals, such as physicians, pharmacists, and hospitals. These relationships are built on trust and long-term collaboration. When sales functions are outsourced to a (CSO), there is a risk that the (CSO)’s actions or performance may not align with the company’s values or quality standards, leading to a negative impact on the company’s reputation. To mitigate this risk, pharmaceutical companies must carefully select reputable and trustworthy CSO that align with their values and quality standards. Robust contracts and clear expectations should be established to ensure compliance with regulations, ethical guidelines, and the company’s sales strategies. Regular monitoring, training, and performance evaluations of the (CSO)’s sales representatives are also essential to maintain alignment with the company’s standards and protect its reputation.

Access To a Highly Trained and Specialized Sales Force

Pharmaceutical companies require skilled sales professionals who possess deep knowledge of the industry, products, and healthcare landscape. However, recruiting, training, and managing an in-house sales team can be time-consuming and resource-intensive. For instance, a pharmaceutical company launching a new product in a specific therapeutic area may lack the necessary in-house expertise to effectively penetrate the market. By partnering with a (CSO) specialized in that therapeutic area, the company gains immediate access to a sales team with in-depth knowledge and established relationships with key healthcare professionals.

Competitive Landscape

Key Players

The global pharmaceutical contract sales outsourcing (CSO) market is highly competitive, with the presence of several key players. Some of the major players in the market and their market share are as follows:

  • IQVIA Inc.
  • Syneos Health Inc.
  • Parexel International Corporation
  • Pharmaceutical Product Development (PPD) LLC
  • inVentiv Health Inc. (part of Syneos Health)
  • ICON plc
  • Publicis Touchpoint Solutions, Inc.
  • PRA Health Sciences, Inc.
  • The Medical Affairs Company (TMAC)
  • Ashfield Healthcare Communications Group (part of UDG Healthcare plc)

These companies focus on service innovation, expanding their Service, mergers, and acquisitions to stay ahead in the market.

The major players in the global pharmaceutical contract sales outsourcing (CSO) market constantly strive to stay ahead by introducing new technologies and innovations.

IQVIA, Inc., entered into partnership with Dr. Reddy’s Laboratories. As per the partnership, IQVIA provided Dr. Reddy with its Orchestrated Customer Engagement (OCE) platform to support its CRM operations.

Summary of Key Findings

  • As pharmaceutical companies are increasingly looking to streamline their operations and reduce costs, making (CSO) an attractive option for sales functions driving market growth
  • Market segmented by service, therapeutic area, and region.
  • Personal promotion is the most popular service segment, with Metabolic disorders therapeutic area as the primary Service segment.
  • Cardiovascular Disorders is the most common therapeutic area segment.
  • North America is leading market growth; the market is highly competitive with key players including IQVIA Inc., Syneos Health Inc., Parexel International Corporation, Pharmaceutical Product Development (PPD) LLC, inVentiv Health Inc. (part of Syneos Health), ICON plc and others.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Future Outlook

  • Positive outlook for the global pharmaceutical contract sales outsourcing (CSO) market with significant growth potential in the North America region
  • Advancements in technology and expanded the reach of pharmaceutical companies due to globalization driving the growth of the market.
  • Challenges like concerns regarding data security and confidentiality when outsourcing sales functions, particularly due to the sensitive nature of pharmaceutical industry information.

Segmentation

By Service,

  • Personal
  • Non-personal

By Offering Segment Analysis

  • Field Sales
  • Telesales
  • Key Account Management
  • Market Access Support
  • Others

By End-user Segment Analysis

  • Pharma Companies
  • Biotech Companies

By Therapeutic Area Segment Analysis

  • Cardiovascular Disorders
  • Oncology
  • Metabolic Disorders
  • Neurology
  • Others (Orthopedic, Infectious Diseases, etc.)

By Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • The U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

Table of Content

Chapter No. 1 :………. Introduction.. 26

1.1.1.  Report Description. 26

Purpose of the Report. 26

USP & Key Offerings. 26

1.1.2.  Key Benefits for Stakeholders. 26

1.1.3.  Target Audience. 27

1.1.4.  Report Scope   27

1.1.5.  Regional Scope   28

Chapter No. 2 :………. Executive Summary. 29

2.1.     Pharmaceutical CSO Market Snapshot. 29

2.1.1.  Global Pharmaceutical CSO Market, 2018 – 2032 (USD Million). 30

Chapter No. 3 :………. Geopolitical Crisis Impact Analysis. 31

3.1.     Russia-Ukraine and Israel-Palestine War Impacts. 31

Chapter No. 4 :………. Pharmaceutical CSO Market – Industry Analysis. 32

4.1.     Introduction   32

4.2.     Market Drivers  33

4.2.1.  Driving Factor 1 Analysis. 33

4.2.2.  Driving Factor 2 Analysis. 34

4.3.     Market Restraints. 35

4.3.1.  Restraining Factor Analysis. 35

4.4.     Market Opportunities. 36

4.4.1.  Market Opportunity Analysis. 36

4.5.     Porter’s Five Forces Analysis. 37

Chapter No. 5 :………. Analysis Competitive Landscape. 38

5.1.     Company Market Share Analysis – 2023. 38

5.1.1.  Global Pharmaceutical CSO Market: Company Market Share, by Volume, 2023. 38

5.1.2.  Global Pharmaceutical CSO Market: Company Market Share, by Revenue, 2023. 39

5.1.3.  Global Pharmaceutical CSO Market: Top 6 Company Market Share, by Revenue, 2023. 39

5.1.4.  Global Pharmaceutical CSO Market: Top 3 Company Market Share, by Revenue, 2023. 40

5.2.     Global Pharmaceutical CSO Market Company Volume Market Share, 2023. 41

5.3.     Global Pharmaceutical CSO Market Company Revenue Market Share, 2023. 42

5.4.     Company Assessment Metrics, 2023. 43

5.4.1.  Stars  43

5.4.2.  Emerging Leaders. 43

5.4.3.  Pervasive Players. 43

5.4.4.  Participants  43

5.5.     Start-ups /SMEs Assessment Metrics, 2023. 43

5.5.1.  Progressive Companies. 43

5.5.2.  Responsive Companies. 43

5.5.3.  Dynamic Companies. 43

5.5.4.  Starting Blocks  43

5.6.     Strategic Developments. 44

5.6.1.  Acquisitions & Mergers. 44

New Product Launch. 44

Regional Expansion. 44

Chapter No. 6 :………. PESTEL & Adjacent Market Analysis. 45

6.1.     PESTEL  45

6.1.1.  Political Factors. 45

6.1.2.  Economic Factors. 45

6.1.3.  Social Factors  45

6.1.4.  Technological Factors. 45

6.1.5.  Environmental Factors. 45

6.1.6.  Legal Factors  45

6.2.     Adjacent Market Analysis. 45

Chapter No. 7 :………. Pharmaceutical CSO Market – By Service Segment Analysis. 46

7.1.     Pharmaceutical CSO Market Overview, by Service Segment. 46

7.1.1.  Pharmaceutical CSO Market Revenue Share, By Service, 2023 & 2032. 47

7.1.2.  Pharmaceutical CSO Market Attractiveness Analysis, By Service. 48

7.1.3.  Incremental Revenue Growth Opportunity, by Service, 2024 – 2032. 48

7.1.4.  Pharmaceutical CSO Market Revenue, By Service, 2018, 2023, 2027 & 2032. 49

7.2.     Personal 50

7.2.1.  Global Personal Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million)  51

7.2.2.  Global Personal Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million)  51

7.3.     Non-personal 52

7.3.1.  Global Non-personal Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million)  53

7.3.2.  Global Non-personal Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million)  53

Chapter No. 8 :………. Pharmaceutical CSO Market – By Offering Segment Analysis  54

8.1.     Pharmaceutical CSO Market Overview, by Offering Segment. 54

8.1.1.  Pharmaceutical CSO Market Revenue Share, By Offering, 2023 & 2032. 55

8.1.2.  Pharmaceutical CSO Market Attractiveness Analysis, By Offering. 56

8.1.3.  Incremental Revenue Growth Opportunity, by Offering, 2024 – 2032. 56

8.1.4.  Pharmaceutical CSO Market Revenue, By Offering, 2018, 2023, 2027 & 2032. 57

8.2.     Field Sales  58

8.2.1.  Global Field Sales Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million)  59

8.2.2.  Global Field Sales Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million)  59

8.3.     Telesales  60

8.3.1.  Global Telesales Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million)  61

8.3.2.  Global Telesales Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million)  61

8.4.     Key Account Management. 62

8.4.1.  Global Key Account Management Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million)  63

8.4.2.  Global Key Account Management Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million)  63

8.5.     Market Access Support. 64

8.5.1.  Global Market Access Support Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million)  65

8.5.2.  Global Market Access Support Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million)  65

8.6.     Others  66

8.6.1.  Global Others Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million)  67

8.6.2.  Global Others Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million)  67

Chapter No. 9 :………. Pharmaceutical CSO Market – By End-user Segment Analysis  68

9.1.     Pharmaceutical CSO Market Overview, by End-user Segment. 68

9.1.1.  Pharmaceutical CSO Market Revenue Share, By End-user, 2023 & 2032. 69

9.1.2.  Pharmaceutical CSO Market Attractiveness Analysis, By End-user. 70

9.1.3.  Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032. 70

9.1.4.  Pharmaceutical CSO Market Revenue, By End-user, 2018, 2023, 2027 & 2032. 71

9.2.     Pharma Companies. 72

9.2.1.  Global Pharma Companies Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million)  73

9.2.2.  Global Pharma Companies Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million)  73

9.3.     Biotech Companies. 74

9.3.1.  Global Biotech Companies Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million)  75

9.3.2.  Global Biotech Companies Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million)  75

Chapter No. 10 :…….. Pharmaceutical CSO Market – By Therapeutic Area Segment Analysis  76

10.1.   Pharmaceutical CSO Market Overview, by Therapeutic Area Segment. 76

10.1.1. Pharmaceutical CSO Market Revenue Share, By Therapeutic Area, 2023 & 2032. 77

10.1.2. Pharmaceutical CSO Market Attractiveness Analysis, By Therapeutic Area. 78

10.1.3. Incremental Revenue Growth Opportunity, by Therapeutic Area, 2024 – 2032. 78

10.1.4. Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2018, 2023, 2027 & 2032. 79

10.2.   Cardiovascular Disorders. 80

10.2.1. Global Cardiovascular Disorders Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million)  81

10.2.2. Global Cardiovascular Disorders Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million)  81

10.3.   Oncology  82

10.3.1. Global Oncology Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million)  83

10.3.2. Global Oncology Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million)  83

10.4.   Metabolic Disorders. 84

10.4.1. Global Metabolic Disorders Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million)  85

10.4.2. Global Metabolic Disorders Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million)  85

10.5.   Neurology  86

10.5.1. Global Neurology Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million)  87

10.5.2. Global Neurology Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million)  87

10.6.   Others (Orthopedic, Infectious Diseases, etc.). 88

10.6.1. Global Others (Orthopedic, Infectious Diseases, etc.) Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million). 89

10.6.2. Global Others (Orthopedic, Infectious Diseases, etc.) Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million). 89

Chapter No. 11 :…….. Pharmaceutical CSO Market – Regional Analysis. 90

11.1.   Pharmaceutical CSO Market Overview, by Regional Segments. 90

11.2.   Region   91

11.2.1. Global Pharmaceutical CSO Market Revenue Share, By Region, 2023 & 2032. 91

11.2.2. Pharmaceutical CSO Market Attractiveness Analysis, By Region. 92

11.2.3. Incremental Revenue Growth Opportunity, by Region, 2024 – 2032. 92

11.2.4. Pharmaceutical CSO Market Revenue, By Region, 2018, 2023, 2027 & 2032. 93

11.2.5. Global Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million). 94

11.2.6. Global Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million). 94

11.3.   Service   95

11.3.1. Global Pharmaceutical CSO Market Revenue, By Service, 2018 – 2023 (USD Million). 95

11.4.   Global Pharmaceutical CSO Market Revenue, By Service, 2024 – 2032 (USD Million). 95

11.5.   Offering  96

11.5.1. Global Pharmaceutical CSO Market Revenue, By Offering, 2018 – 2023 (USD Million). 96

11.5.2. Global Pharmaceutical CSO Market Revenue, By Offering, 2024 – 2032 (USD Million). 96

11.6.   End-user  97

11.6.1. Global Pharmaceutical CSO Market Revenue, By End-user, 2018 – 2023 (USD Million). 97

11.6.2. Global Pharmaceutical CSO Market Revenue, By End-user, 2024 – 2032 (USD Million). 97

11.7.   Therapeutic Area. 98

11.7.1. Global Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million)  98

11.7.2. Global Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million)  98

Chapter No. 12 :…….. Pharmaceutical CSO Market – North America.. 99

12.1.   North America  99

12.1.1. Key Highlights  99

12.1.2. North America Pharmaceutical CSO Market Revenue, By Country, 2018 – 2023 (USD Million)  100

12.1.3. North America Pharmaceutical CSO Market Revenue, By Service, 2018 – 2023 (USD Million)  101

12.1.4. North America Pharmaceutical CSO Market Revenue, By Offering, 2018 – 2023 (USD Million)  102

12.1.5. North America Pharmaceutical CSO Market Revenue, By End-user, 2018 – 2023 (USD Million)  103

12.1.6. North America Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million)  104

12.2.   U.S. 105

12.3.   Canada  105

12.4.   Mexico   105

Chapter No. 13 :…….. Pharmaceutical CSO Market – Europe. 106

13.1.   Europe   106

13.1.1. Key Highlights  106

13.1.2. Europe Pharmaceutical CSO Market Revenue, By Country, 2018 – 2023 (USD Million). 107

13.1.3. Europe Pharmaceutical CSO Market Revenue, By Service, 2018 – 2023 (USD Million). 108

13.1.4. Europe Pharmaceutical CSO Market Revenue, By Offering, 2018 – 2023 (USD Million). 109

13.1.5. Europe Pharmaceutical CSO Market Revenue, By End-user, 2018 – 2023 (USD Million). 110

13.1.6. Europe Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million)  111

13.2.   UK   112

13.3.   France   112

13.4.   Germany  112

13.5.   Italy  112

13.6.   Spain   112

13.7.   Russia  112

13.8.   Belgium    112

13.9.   Netherland   112

13.10.  Austria  112

13.11.  Sweden   112

13.12.  Poland   112

13.13.  Denmark  112

13.14.  Switzerland   112

13.15.  Rest of Europe   112

Chapter No. 14 :…….. Pharmaceutical CSO Market – Asia Pacific. 113

14.1.   Asia Pacific  113

14.1.1. Key Highlights  113

14.1.2. Asia Pacific Pharmaceutical CSO Market Revenue, By Country, 2018 – 2023 (USD Million). 114

14.1.3. Asia Pacific Pharmaceutical CSO Market Revenue, By Service, 2018 – 2023 (USD Million). 115

14.1.4. Asia Pacific Pharmaceutical CSO Market Revenue, By Offering, 2018 – 2023 (USD Million). 116

14.1.5. Asia Pacific Pharmaceutical CSO Market Revenue, By End-user, 2018 – 2023 (USD Million)  117

14.1.6. Asia Pacific Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million)  118

14.2.   China  119

14.3.   Japan   119

14.4.   South Korea  119

14.5.   India  119

14.6.   Australia  119

14.7.   Thailand   119

14.8.   Indonesia  119

14.9.   Vietnam    119

14.10.  Malaysia  119

14.11.  Philippines  119

14.12.  Taiwan   119

14.13.  Rest of Asia Pacific. 119

Chapter No. 15 :…….. Pharmaceutical CSO Market – Latin America.. 120

15.1.   Latin America  120

15.1.1. Key Highlights  120

15.1.2. Latin America Pharmaceutical CSO Market Revenue, By Country, 2018 – 2023 (USD Million)  121

15.1.3. Latin America Pharmaceutical CSO Market Revenue, By Service, 2018 – 2023 (USD Million)  122

15.1.4. Latin America Pharmaceutical CSO Market Revenue, By Offering, 2018 – 2023 (USD Million)  123

15.1.5. Latin America Pharmaceutical CSO Market Revenue, By End-user, 2018 – 2023 (USD Million)  124

15.1.6. Latin America Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million)  125

15.2.   Brazil 126

15.3.   Argentina  126

15.4.   Peru   126

15.5.   Chile   126

15.6.   Colombia  126

15.7.   Rest of Latin America. 126

Chapter No. 16 :…….. Pharmaceutical CSO Market – Middle East. 127

16.1.   Middle East  127

16.1.1. Key Highlights  127

16.1.2. Middle East Pharmaceutical CSO Market Revenue, By Country, 2018 – 2023 (USD Million)  128

16.1.3. Middle East Pharmaceutical CSO Market Revenue, By Service, 2018 – 2023 (USD Million). 129

16.1.4. Middle East Pharmaceutical CSO Market Revenue, By Offering, 2018 – 2023 (USD Million)  130

16.1.5. Middle East Pharmaceutical CSO Market Revenue, By End-user, 2018 – 2023 (USD Million)  131

16.1.6. Middle East Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million)  132

16.2.   UAE  133

16.3.   KSA   133

16.4.   Israel 133

16.5.   Turkey  133

16.6.   Iran   133

16.7.   Rest of Middle East. 133

Chapter No. 17 :…….. Pharmaceutical CSO Market – Africa.. 134

17.1.   Africa  134

17.1.1. Key Highlights  134

17.1.2. Africa Pharmaceutical CSO Market Revenue, By Country, 2018 – 2023 (USD Million). 135

17.1.3. Africa Pharmaceutical CSO Market Revenue, By Service, 2018 – 2023 (USD Million). 136

17.1.4. Africa Pharmaceutical CSO Market Revenue, By Offering, 2018 – 2023 (USD Million). 137

17.1.5. Africa Pharmaceutical CSO Market Revenue, By End-user, 2018 – 2023 (USD Million). 138

17.1.6. Africa Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million)  139

17.2.   Egypt  140

17.3.   Nigeria  140

17.4.   Algeria  140

17.5.   Morocco   140

17.6.   Rest of Africa  140

Chapter No. 18 :…….. Company Profiles. 141

18.1.   IQVIA Inc. 141

18.1.1. Company Overview.. 141

18.1.2. Product Portfolio. 141

18.1.3. Swot Analysis  141

18.1.4. Business Strategy. 142

18.1.5. Financial Overview.. 142

18.2.   Syneos Health Inc. 143

18.3.   Parexel International Corporation. 143

18.4.   Pharmaceutical Product Development (PPD) LLC. 143

18.5.   inVentiv Health Inc. (part of Syneos Health). 143

18.6.   ICON plc  143

18.7.   Publicis Touchpoint Solutions, Inc. 143

18.8.   PRA Health Sciences, Inc. 143

18.9.   The Medical Affairs Company (TMAC). 143

18.10.  Ashfield Healthcare Communications Group. 143

18.11.  CMIC Holdings Co., Ltd. 143

18.12.  Axxelus  143

18.13.  EPS Corp. 143

18.14.  QFR Solutions  143

18.15.  MaBico   143

18.16.  Mednext Pharma Pvt. Ltd. 143

18.17.  Peak Pharma Solutions Inc. 143

18.18.  Promoveo Health. 143

Chapter No. 19 :…….. Research Methodology. 144

19.1.   Research Methodology. 144

19.1.1. Phase I – Secondary Research. 145

19.1.2. Phase II – Data Modeling. 145

Company Share Analysis Model 146

Revenue Based Modeling. 146

19.1.3. Phase III – Primary Research. 147

19.1.4. Research Limitations. 148

Assumptions. 148

 

List of Figures

FIG NO. 1………. Global Pharmaceutical CSO Market Revenue, 2018 – 2032 (USD Million) 29

FIG NO. 2………. Porter’s Five Forces Analysis for Global Pharmaceutical CSO Market 36

FIG NO. 3………. Company Share Analysis, 2023. 37

FIG NO. 4………. Company Share Analysis, 2023. 38

FIG NO. 5………. Company Share Analysis, 2023. 38

FIG NO. 6………. Company Share Analysis, 2023. 39

FIG NO. 7………. Pharmaceutical CSO Market – Company Volume  Market Share, 2023. 40

FIG NO. 8………. Pharmaceutical CSO Market – Company Revenue Market Share, 2023. 41

FIG NO. 9………. Pharmaceutical CSO Market Revenue Share, By Service, 2023 & 2032. 46

FIG NO. 10……… Market Attractiveness Analysis, By Service. 47

FIG NO. 11……… Incremental Revenue Growth Opportunity by Service, 2024 – 2032. 47

FIG NO. 12……… Pharmaceutical CSO Market Revenue, By Service, 2018, 2023, 2027 & 2032. 48

FIG NO. 13……… Global Pharmaceutical CSO Market for Personal, Revenue (USD Million) 2018 – 2032. 49

FIG NO. 14……… Global Pharmaceutical CSO Market for Non-personal, Revenue (USD Million) 2018 – 2032. 51

FIG NO. 15……… Pharmaceutical CSO Market Revenue Share, By Offering, 2023 & 2032. 54

FIG NO. 16……… Market Attractiveness Analysis, By Offering. 55

FIG NO. 17……… Incremental Revenue Growth Opportunity by Offering, 2024 – 2032. 55

FIG NO. 18……… Pharmaceutical CSO Market Revenue, By Offering, 2018, 2023, 2027 & 2032. 56

FIG NO. 19……… Global Pharmaceutical CSO Market for Field Sales, Revenue (USD Million) 2018 – 2032. 57

FIG NO. 20……… Global Pharmaceutical CSO Market for Telesales, Revenue (USD Million) 2018 – 2032. 59

FIG NO. 21……… Global Pharmaceutical CSO Market for Key Account Management, Revenue (USD Million) 2018 – 2032  61

FIG NO. 22……… Global Pharmaceutical CSO Market for Market Access Support, Revenue (USD Million) 2018 – 2032  63

FIG NO. 23……… Global Pharmaceutical CSO Market for Others, Revenue (USD Million) 2018 – 2032. 65

FIG NO. 24……… Pharmaceutical CSO Market Revenue Share, By End-user, 2023 & 2032. 68

FIG NO. 25……… Market Attractiveness Analysis, By End-user. 69

FIG NO. 26……… Incremental Revenue Growth Opportunity by End-user, 2024 – 2032. 69

FIG NO. 27……… Pharmaceutical CSO Market Revenue, By End-user, 2018, 2023, 2027 & 2032. 70

FIG NO. 28……… Global Pharmaceutical CSO Market for Pharma Companies, Revenue (USD Million) 2018 – 2032  71

FIG NO. 29……… Global Pharmaceutical CSO Market for Biotech Companies, Revenue (USD Million) 2018 – 2032  73

FIG NO. 30……… Pharmaceutical CSO Market Revenue Share, By Therapeutic Area, 2023 & 2032. 76

FIG NO. 31……… Market Attractiveness Analysis, By Therapeutic Area. 77

FIG NO. 32……… Incremental Revenue Growth Opportunity by Therapeutic Area, 2024 – 2032. 77

FIG NO. 33……… Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2018, 2023, 2027 & 2032. 78

FIG NO. 34……… Global Pharmaceutical CSO Market for Cardiovascular Disorders, Revenue (USD Million) 2018 – 2032  79

FIG NO. 35……… Global Pharmaceutical CSO Market for Oncology, Revenue (USD Million) 2018 – 2032. 81

FIG NO. 36……… Global Pharmaceutical CSO Market for Metabolic Disorders, Revenue (USD Million) 2018 – 2032  83

FIG NO. 37……… Global Pharmaceutical CSO Market for Neurology, Revenue (USD Million) 2018 – 2032. 85

FIG NO. 38……… Global Pharmaceutical CSO Market for Others (Orthopedic, Infectious Diseases, etc.), Revenue (USD Million) 2018 – 2032. 87

FIG NO. 39……… Global Pharmaceutical CSO Market Revenue Share, By Region, 2023 & 2032. 90

FIG NO. 40……… Market Attractiveness Analysis, By Region. 91

FIG NO. 41……… Incremental Revenue Growth Opportunity by Region, 2024 – 2032. 91

FIG NO. 42……… Pharmaceutical CSO Market Revenue, By Region, 2018, 2023, 2027 & 2032. 92

FIG NO. 43……… North America Pharmaceutical CSO Market Revenue, 2018 – 2032 (USD Million) 98

FIG NO. 44……… Europe Pharmaceutical CSO Market Revenue, 2018 – 2032 (USD Million) 105

FIG NO. 45……… Asia Pacific Pharmaceutical CSO Market Revenue, 2018 – 2032 (USD Million) 112

FIG NO. 46……… Latin America Pharmaceutical CSO Market Revenue, 2018 – 2032 (USD Million) 119

FIG NO. 47……… Middle East Pharmaceutical CSO Market Revenue, 2018 – 2032 (USD Million) 126

FIG NO. 48……… Africa Pharmaceutical CSO Market Revenue, 2018 – 2032 (USD Million) 133

FIG NO. 49……… Research Methodology – Detailed View.. 143

FIG NO. 50……… Research Methodology. 144

 

 

List of Tables

TABLE NO. 1. :…. Global Pharmaceutical CSO Market: Snapshot 26

TABLE NO. 2. :…. Drivers for the Pharmaceutical CSO Market: Impact Analysis. 30

TABLE NO. 3. :…. Restraints for the Pharmaceutical CSO Market: Impact Analysis. 32

TABLE NO. 4. :…. Global Personal Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million) 48

TABLE NO. 5. :…. Global Personal Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million) 48

TABLE NO. 6. :…. Global Non-personal Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million) 50

TABLE NO. 7. :…. Global Non-personal Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million) 50

TABLE NO. 8. :…. Global Field Sales Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million) 56

TABLE NO. 9. :…. Global Field Sales Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million) 56

TABLE NO. 10. :.. Global Telesales Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million) 58

TABLE NO. 11. :.. Global Telesales Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million) 58

TABLE NO. 12. :.. Global Key Account Management Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million) 60

TABLE NO. 13. :.. Global Key Account Management Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million) 60

TABLE NO. 14. :.. Global Market Access Support Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million) 62

TABLE NO. 15. :.. Global Market Access Support Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million) 62

TABLE NO. 16. :.. Global Others Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million) 64

TABLE NO. 17. :.. Global Others Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million) 64

TABLE NO. 18. :.. Global Pharma Companies Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million) 70

TABLE NO. 19. :.. Global Pharma Companies Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million) 70

TABLE NO. 20. :.. Global Biotech Companies Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million) 72

TABLE NO. 21. :.. Global Biotech Companies Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million) 72

TABLE NO. 22. :.. Global Cardiovascular Disorders Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million) 78

TABLE NO. 23. :.. Global Cardiovascular Disorders Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million) 78

TABLE NO. 24. :.. Global Oncology Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million) 80

TABLE NO. 25. :.. Global Oncology Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million) 80

TABLE NO. 26. :.. Global Metabolic Disorders Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million) 82

TABLE NO. 27. :.. Global Metabolic Disorders Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million) 82

TABLE NO. 28. :.. Global Neurology Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million) 84

TABLE NO. 29. :.. Global Neurology Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million) 84

TABLE NO. 30. :.. Global Others (Orthopedic, Infectious Diseases, etc.) Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million) 86

TABLE NO. 31. :.. Global Others (Orthopedic, Infectious Diseases, etc.) Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million) 86

TABLE NO. 32. :.. Global Pharmaceutical CSO Market Revenue, By Region, 2018 – 2023 (USD Million) 91

TABLE NO. 33. :.. Global Pharmaceutical CSO Market Revenue, By Region, 2024 – 2032 (USD Million) 91

TABLE NO. 34. :.. Global Pharmaceutical CSO Market Revenue, By Service, 2018 – 2023 (USD Million) 92

TABLE NO. 35. :.. Global Pharmaceutical CSO Market Revenue, By Service, 2024 – 2032 (USD Million) 92

TABLE NO. 36. :.. Global Pharmaceutical CSO Market Revenue, By Offering, 2018 – 2023 (USD Million) 93

TABLE NO. 37. :.. Global Pharmaceutical CSO Market Revenue, By Offering, 2024 – 2032 (USD Million) 93

TABLE NO. 38. :.. Global Pharmaceutical CSO Market Revenue, By End-user, 2018 – 2023 (USD Million) 94

TABLE NO. 39. :.. Global Pharmaceutical CSO Market Revenue, By End-user, 2024 – 2032 (USD Million) 94

TABLE NO. 40. :.. Global Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 95

TABLE NO. 41. :.. Global Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 95

TABLE NO. 42. :.. North America Pharmaceutical CSO Market Revenue, By Country, 2018 – 2023 (USD Million) 97

TABLE NO. 43. :.. North America Pharmaceutical CSO Market Revenue, By Country, 2024 – 2032 (USD Million) 97

TABLE NO. 44. :.. North America Pharmaceutical CSO Market Revenue, By Service, 2018 – 2023 (USD Million) 98

TABLE NO. 45. :.. North America Pharmaceutical CSO Market Revenue, By Service, 2024 – 2032 (USD Million) 98

TABLE NO. 46. :.. North America Pharmaceutical CSO Market Revenue, By Offering, 2018 – 2023 (USD Million) 99

TABLE NO. 47. :.. North America Pharmaceutical CSO Market Revenue, By Offering, 2024 – 2032 (USD Million) 99

TABLE NO. 48. :.. North America Pharmaceutical CSO Market Revenue, By End-user, 2018 – 2023 (USD Million) 100

TABLE NO. 49. :.. North America Pharmaceutical CSO Market Revenue, By End-user, 2024 – 2032 (USD Million) 100

TABLE NO. 50. :.. North America Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 101

TABLE NO. 51. :.. North America Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 101

TABLE NO. 52. :.. Europe Pharmaceutical CSO Market Revenue, By Country, 2018 – 2023 (USD Million) 104

TABLE NO. 53. :.. Europe Pharmaceutical CSO Market Revenue, By Country, 2024 – 2032 (USD Million) 104

TABLE NO. 54. :.. Europe Pharmaceutical CSO Market Revenue, By Service, 2018 – 2023 (USD Million) 105

TABLE NO. 55. :.. Europe Pharmaceutical CSO Market Revenue, By Service, 2024 – 2032 (USD Million) 105

TABLE NO. 56. :.. Europe Pharmaceutical CSO Market Revenue, By Offering, 2018 – 2023 (USD Million) 106

TABLE NO. 57. :.. Europe Pharmaceutical CSO Market Revenue, By Offering, 2024 – 2032 (USD Million) 106

TABLE NO. 58. :.. Europe Pharmaceutical CSO Market Revenue, By End-user, 2018 – 2023 (USD Million) 107

TABLE NO. 59. :.. Europe Pharmaceutical CSO Market Revenue, By End-user, 2024 – 2032 (USD Million) 107

TABLE NO. 60. :.. Europe Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 108

TABLE NO. 61. :.. Europe Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 108

TABLE NO. 62. :.. Asia Pacific Pharmaceutical CSO Market Revenue, By Country, 2018 – 2023 (USD Million) 111

TABLE NO. 63. :.. Asia Pacific Pharmaceutical CSO Market Revenue, By Country, 2024 – 2032 (USD Million) 111

TABLE NO. 64. :.. Asia Pacific Pharmaceutical CSO Market Revenue, By Service, 2018 – 2023 (USD Million) 112

TABLE NO. 65. :.. Asia Pacific Pharmaceutical CSO Market Revenue, By Service, 2024 – 2032 (USD Million) 112

TABLE NO. 66. :.. Asia Pacific Pharmaceutical CSO Market Revenue, By Offering, 2018 – 2023 (USD Million) 113

TABLE NO. 67. :.. Asia Pacific Pharmaceutical CSO Market Revenue, By Offering, 2024 – 2032 (USD Million) 113

TABLE NO. 68. :.. Asia Pacific Pharmaceutical CSO Market Revenue, By End-user, 2018 – 2023 (USD Million) 114

TABLE NO. 69. :.. Asia Pacific Pharmaceutical CSO Market Revenue, By End-user, 2024 – 2032 (USD Million) 114

TABLE NO. 70. :.. Asia Pacific Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 115

TABLE NO. 71. :.. Asia Pacific Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 115

TABLE NO. 72. :.. Latin America Pharmaceutical CSO Market Revenue, By Country, 2018 – 2023 (USD Million) 118

TABLE NO. 73. :.. Latin America Pharmaceutical CSO Market Revenue, By Country, 2024 – 2032 (USD Million) 118

TABLE NO. 74. :.. Latin America Pharmaceutical CSO Market Revenue, By Service, 2018 – 2023 (USD Million) 119

TABLE NO. 75. :.. Latin America Pharmaceutical CSO Market Revenue, By Service, 2024 – 2032 (USD Million) 119

TABLE NO. 76. :.. Latin America Pharmaceutical CSO Market Revenue, By Offering, 2018 – 2023 (USD Million) 120

TABLE NO. 77. :.. Latin America Pharmaceutical CSO Market Revenue, By Offering, 2024 – 2032 (USD Million) 120

TABLE NO. 78. :.. Latin America Pharmaceutical CSO Market Revenue, By End-user, 2018 – 2023 (USD Million) 121

TABLE NO. 79. :.. Latin America Pharmaceutical CSO Market Revenue, By End-user, 2024 – 2032 (USD Million) 121

TABLE NO. 80. :.. Latin America Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 122

TABLE NO. 81. :.. Latin America Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 122

TABLE NO. 82. :.. Middle East Pharmaceutical CSO Market Revenue, By Country, 2018 – 2023 (USD Million) 125

TABLE NO. 83. :.. Middle East Pharmaceutical CSO Market Revenue, By Country, 2024 – 2032 (USD Million) 125

TABLE NO. 84. :.. Middle East Pharmaceutical CSO Market Revenue, By Service, 2018 – 2023 (USD Million) 126

TABLE NO. 85. :.. Middle East Pharmaceutical CSO Market Revenue, By Service, 2024 – 2032 (USD Million) 126

TABLE NO. 86. :.. Middle East Pharmaceutical CSO Market Revenue, By Offering, 2018 – 2023 (USD Million) 127

TABLE NO. 87. :.. Middle East Pharmaceutical CSO Market Revenue, By Offering, 2024 – 2032 (USD Million) 127

TABLE NO. 88. :.. Middle East Pharmaceutical CSO Market Revenue, By End-user, 2018 – 2023 (USD Million) 128

TABLE NO. 89. :.. Middle East Pharmaceutical CSO Market Revenue, By End-user, 2024 – 2032 (USD Million) 128

TABLE NO. 90. :.. Middle East Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 129

TABLE NO. 91. :.. Middle East Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 129

TABLE NO. 92. :.. Africa Pharmaceutical CSO Market Revenue, By Country, 2018 – 2023 (USD Million) 132

TABLE NO. 93. :.. Africa Pharmaceutical CSO Market Revenue, By Country, 2024 – 2032 (USD Million) 132

TABLE NO. 94. :.. Africa Pharmaceutical CSO Market Revenue, By Service, 2018 – 2023 (USD Million) 133

TABLE NO. 95. :.. Africa Pharmaceutical CSO Market Revenue, By Service, 2024 – 2032 (USD Million) 133

TABLE NO. 96. :.. Africa Pharmaceutical CSO Market Revenue, By Offering, 2018 – 2023 (USD Million) 134

TABLE NO. 97. :.. Africa Pharmaceutical CSO Market Revenue, By Offering, 2024 – 2032 (USD Million) 134

TABLE NO. 98. :.. Africa Pharmaceutical CSO Market Revenue, By End-user, 2018 – 2023 (USD Million) 135

TABLE NO. 99. :.. Africa Pharmaceutical CSO Market Revenue, By End-user, 2024 – 2032 (USD Million) 135

TABLE NO. 100. : Africa Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 136

TABLE NO. 101. : Africa Pharmaceutical CSO Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 136

 

Frequently Asked Questions:

What is the current size of the global pharmaceutical contract sales outsourcing (CSO) market?

The global pharmaceutical contract sales outsourcing (CSO) market was valued at USD 9.3 Billion in 2022.

What is the expected growth rate of the pharmaceutical contract sales outsourcing (CSO) market between 2023 and 2030?

The Pharmaceutical contract sales outsourcing (CSO) market is expected to grow at a CAGR of 7.30% between 2023 and 2030, reaching USD 15.22933719 Billion in 2030.

Which segment is leading the market share in terms of service?

Personal promotion service vaccine is the leading segment by service, holding around more than four-fifth of the share in value in 2022.

Which therapeutic area governs the demand for pharmaceutical contract sales outsourcing (CSO) market in the world?

Cardiovascular Disorders governs the demand for pharmaceutical contract sales outsourcing (CSO) globally, holding a massive share of nearly 35% in 2022.

Which segment is expected to post the highest CAGR during the forecast period?

Metabolic disorders therapeutic area segment is expected to post the highest CAGR during the forecast period.

Which region is fueling the growth of the pharmaceutical contract sales outsourcing (CSO) industry?

North America is fueling the growth of the pharmaceutical contract sales outsourcing (CSO) industry, with nearly a three-firth share in 2022.

Who are the major players in the global pharmaceutical contract sales outsourcing (CSO) market?

The top players include IQVIA Inc., Syneos Health Inc., Parexel International Corporation, Pharmaceutical Product Development (PPD) LLC, inVentiv Health Inc. (part of Syneos Health), ICON plc and others.

What is the major market driver of the pharmaceutical contract sales outsourcing (CSO) industry?

As pharmaceutical companies are increasingly looking to streamline their operations and reduce costs, making (CSO) an attractive option for sales functions & expanded the reach of pharmaceutical companies due to globalization are some of the market drivers.

What are the major market restraints of the pharmaceutical contract sales outsourcing (CSO) industry?

Rising scrutiny and regulations within the healthcare industry that can impact the operations and compliance of CSO & availability of skilled and experienced sales professionals for outsourcing purposes still restraints on the pharmaceutical contract sales outsourcing (CSO) industry.

What are the major market opportunities of the pharmaceutical contract sales outsourcing (CSO) industry?

CSO offer pharmaceutical companies access to a highly trained and specialized sales force without the need for extensive recruitment and training efforts & they can assist in navigating complex regulatory environments, ensuring compliance, and minimizing risks are some of the opportunities of the market.

Quality Management Software Market

Published:
Report ID: 8459

Multichannel Order Management Market

Published:
Report ID: 24142

Architecture Engineering and Construction (AEC) Software Market

Published:
Report ID: 19572

Loan-Servicing Software Market

Published:
Report ID: 19516

Blockchain in BFSI Market

Published:
Report ID: 19053

Enterprise Agile Transformation Services Market

Published:
Report ID: 19031

Fintech Software Market

Published:
Report ID: 18741

Offshore Structural Analysis Software Market

Published:
Report ID: 7488

PC Processor Market

Published:
Report ID: 8951

Cleaning Validation Software for Pharma Market

Published:
Report ID: 3542

Test And Burn-in Sockets Market

Published:
Report ID: 11111

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN